Trial Profile
Clinical and metabolic effects of rosiglitazone and metformin in non-obese women with polycystic ovary syndrome and metabolic disorders: a randomized controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Rosiglitazone (Primary)
- Indications Metabolic disorders; Polycystic ovary syndrome
- Focus Pharmacodynamics
- 01 Mar 2016 Status changed from not yet recruiting to completed.
- 03 Sep 2013 New trial record